ALSDPEGNCT05336760
Dysphagia, QoL and Attitudes Towards PEG in ALS Patients
StatusRecruiting
PhaseNot specified
Primary completion (estimated)
At risk: Primary completion moved 3 months later.
See at-risk trials from University Rehabilitation Institute, Republic of Slovenia
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 7 versions: 6 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 8 words
- Primary and study completion pushed from Sep 30, 2026 to Dec 30, 2026
- Secondary endpoints: details revised at 3 of 8 entries
- Notable Primary and study completion dates: Mar 31, 2026 to Sep 30, 2026v6
- Notable Trial status: Not Yet Recruiting to Recruiting
- Primary and study completion dates: Mar 31, 2025 to Mar 31, 2026
- Start date changed from estimate of Aug 1, 2022 to Jan 1, 2023
- Site details revised
- Notable Start date: May 31, 2022 to Aug 1, 2022v3
- Notable Start date: May 1, 2022 to May 31, 2022v2
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Penetration-Aspiration Scale (PAS) change
Timeframe: Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
Yale Residue Severity Rating Scale (YRSRS) change
Timeframe: Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
Iowa Oral Performance Instrument (IOPI) change
Timeframe: Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
Mann Assessment of Swallowing Ability (MASA) change
Timeframe: Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
Eating Assessment Tool 10 (EAT-10) change
Timeframe: Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
Swallowing Quality of Life Questionnaire (SWAL-QoL) change
Timeframe: At baseline and every 3 months until PEG insertion, 3 and 6 months after PEG insertion
Questionnaire on Attitudes Toward PEG Tube Feeding and Insertion Procedure change
Timeframe: Difference between baseline and PEG insertion (usually in 6-25 months after diagnosis, maximum follow-up 30 months)
Secondary (8)
ALS Functional Rating Scale-Revised (ALSFRS-R) change
Functional Oral Intake Scale (FOIS) change
Dysphagia Outcome and Severity Scale (DOSS) change
BMI change
Forced Vital Capacity (FVC) change
Show 3 moreShow less
Peak Cough Flow (PCF) change
Maximal Inspiratory Pressure (MIP) change
Maximal Expiratory Pressure (MEP) change
Arms and interventions
ALS Patients
Patients with confirmed amyotrophic lateral sclerosis.
Relatives
Close relatives of the patients included in the study.
Diagnostic tests: Iowa Oral Performance Instrument (IOPI), Mann Assessment of Swallowing Ability (MASA), Fiberoptic Endoscopic Evaluation of Swallowing, Respiratory function measurements
Sites
1 site in 1 country
- University Medical Centre LjubljanaLjubljana, Slovenia